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A 3-year-old boy, with pre-B acute lymphoblastic 
leukaemia, on chemotherapy, was hospitalized for the 
antibiotic and antifungal therapy for the febrile neutropenia 
(white blood cell count 0.71 × 103 ul). During the course 
of treatment, computed tomography (CT) maxillofacial 
was performed for the evaluation of fungal sinusitis, and 
subsequently, magnetic resonance imaging (MRI) brain 
was advised for possible intracranial extension of disease.
On the MRI brain, there was an incidental note of a large 
mass located in the right periventricular/periatrial white 
matter which demonstrated diffusion restriction on driving 
while intoxicated (DWI) and analogue-to-digital converter 
(ADC) images, no contrast enhancement on T1 fat-saturated 
post-gadolinium images, mild T2/FLAIR hyperintensity 
and punctate foci of haemorrhages on gradient-recalled 
echo images [Figure 1]. This mass was demonstrating mass 
effect on the adjacent brain and ventricle. There was no 
leptomeningeal disease or peripheral vasogenic oedema. 
On the basis of imaging, we favoured the diagnosis of 
central nervous system lymphoma (CNSL) in this immune-
compromised patient. This lesion was demonstrating 
mass effect, hypercellularity (as indicated by significant 
diffusion restriction), intratumoural haemorrhagic foci, 
periventricular location and no contrast enhancement. 
The patient died the same day of the MRI scan due to 
febrile neutropenia. The other diagnostic considerations 
were infection, infarct and metastasis. The images did not 
show peripheral hypointense rim on T2-weighted images, 
no ring-like enhancement or central diffusion restriction 
which is are key features of an intracerebral abscess. 
Furthermore, the lesion demonstrated mass effect and does 
not involve overlying cortex, rendering the diagnosis of 
infarct less likely. The differential diagnosis for metastasis 
was less likely, as there was no peripheral vasogenic 
oedema or contrast enhancement.
Immunosuppression, congenital or acquired, increases the 
risk of developing CNS lymphoma.[1] Primary CNSL in 
immunosuppressed patients presents with variable imaging 
features. The lesions can be non-enhancing[2], as in our case; 
furthermore, irregular or ring enhancement patterns can be 
seen addition to haemorrhage and necrosis in these patients.[2]
DWI indicates the diffusion of water molecules in the 
tissues; diffusion within the tumour is known to be a 
surrogate marker of tumour cellularity because densely 
packed cells constitute a barrier to water diffusion. The CNS 
lymphomas are highly cellular tumours, causing restriction 
of the water diffusion, making them appear hyperintense 
on DWI and hypointense on ADC maps. Our case has the 
limitation that the patient did not survive long enough to 
have advanced MRI or positron-emission tomography 
imaging or, brain biopsy or cerebrospinal fluid studies to 
confirm the findings; however, the above-mentioned MR 
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Figure 1: Axial driving while intoxicated and analogue-to-
digital converter magnetic resonance (MR) images show 
diffusion restriction in the right periatrial tumour; increased 
signal intensity relative to grey matter in the tumour with 
mild peritumoural oedema (T2 and FLAIR MR images) and 
mass effect on the ventricle. Axial gradient-recalled echo MR 
image reveals foci of haemorrhages within the tumour. Axial 
T1 post-gadolinium fat-saturated MR images show no contrast 
enhancement in this immunocompromised patient
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features and mass effect by the tumour are important to 
narrow the differential diagnosis. In addition to the MRI 
brainwith and without gadolinium, the complete physical, 
neurological and ophthalmological examination are 
necessary.[3] The secondary CNS lymphoma and primary 
CNS lymphoma can be differentiated on the basis of bone 
marrow biopsy, testicular ultrasound and CT of the chest, 
abdomen and pelvis. Stereotactic biopsy of the tumour is 
the gold standard for the final diagnosis of lymphoma.[3]
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